Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Brown

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Biomaterials|January 18, 2014
Myocardial contraction and hyaluronic acid mechanotransduction in epithelial-to-mesenchymal transformation of endocardial cellsMary Kathryn Sewell-Loftin, Daniel M DeLaughter, Jon R Peacock, et al.
Cellular Signalling|January 13, 2012
BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasionCynthia R Hill, Nora S Sanchez, Joseph D Love, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inflammatory stimuli up-regulate secretion of the soluble GM-CSF receptor in human monocytes: evidence for ectodomain shedding of the cell surface GM-CSF receptor alpha subunitJay M Prevost, Jennifer L Pelley, Weibin Zhu, et al.
Developmental Biology|August 30, 2011
The cytoplasmic domain of TGFβR3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behaviorNora S Sánchez, Cynthia R Hill, Joseph D Love, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulinJames A Russell, Mary Lynn Savoie, Alexander Balogh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk diseaseJames A Russell, Qiuli Duan, M Ahsan Chaudhry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2009
The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemiaJames A Russell, William Irish, Alexander Balogh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantationJames A Russell, Shahbal B Kangarloo, Tyler Williamson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosingS Bill Kangarloo, Farrukh Naveed, Ella S M Ng, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Biomaterials|January 18, 2014
Myocardial contraction and hyaluronic acid mechanotransduction in epithelial-to-mesenchymal transformation of endocardial cellsMary Kathryn Sewell-Loftin, Daniel M DeLaughter, Jon R Peacock, et al.
Cellular Signalling|January 13, 2012
BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasionCynthia R Hill, Nora S Sanchez, Joseph D Love, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inflammatory stimuli up-regulate secretion of the soluble GM-CSF receptor in human monocytes: evidence for ectodomain shedding of the cell surface GM-CSF receptor alpha subunitJay M Prevost, Jennifer L Pelley, Weibin Zhu, et al.
Developmental Biology|August 30, 2011
The cytoplasmic domain of TGFβR3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behaviorNora S Sánchez, Cynthia R Hill, Joseph D Love, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulinJames A Russell, Mary Lynn Savoie, Alexander Balogh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk diseaseJames A Russell, Qiuli Duan, M Ahsan Chaudhry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2009
The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemiaJames A Russell, William Irish, Alexander Balogh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantationJames A Russell, Shahbal B Kangarloo, Tyler Williamson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosingS Bill Kangarloo, Farrukh Naveed, Ella S M Ng, et al.
Pageof 4